Philadelphia Phillies v Atlanta Braves

Today’s decision punishes A-Rod, but it also gives Bud Selig new power

66 Comments

I think the most interesting thing about Alex Rodriguez’s suspension is that curious number of games: 162. It’s such a great number. It matches up so perfectly with a major league baseball season! I thought Ryan Braun’s suspension was interesting too: 65 games. When, as a matter of pure coincidence, I’m sure, the Milwaukee Brewers had 65 games left on their schedule. How neat that is!

It’s almost as if we now have a new matrix for drug suspensions:

  • First offense: 50 games
  • Second offense: 100 games
  • Third offense: lifetime ban
  • Offense by a guy who REALLY makes us look bad and we want to hammer: Until the end of the year, how ever many games that may be.

Which, however satisfying that may be — who doesn’t want A-Rod to just be gone for a season at this point? — is a departure from what Major League Baseball has done with suspensions in the past. Until Braun and now A-Rod, suspensions were for a set number of games, agreed-to beforehand in the Joint Drug Agreement. It was automatic, not a matter of personal judgment by Bud Selig or an arbitrator. We’re in new territory here.

The explanation I’ve seen from some on this — particularly Tom Verducci, but others have said it as well — is that the odd, convenient number of games is because the enforcement action was not based on testing, it was based on non-analytic information (Tony Bosch and the Biogenesis documents) and that when we’re in non-analytic land, the Commissioner has discretion.

Except that is not at all clear from either the terms of the CBA or the JDA. It’s apparently what Bud Selig asserted and, presumably, it’s a position the arbitrator validated in the A-Rod arbitration. But we don’t know, because his decision is sealed. I wonder if, given how much time A-Rod’s lawyers seemed to spend on claiming the existence of a vast conspiracy against their client, they bothered to spend much time arguing that point of the Commissioner’s authority. If they didn’t, that’s pretty awful lawyering.

In any event, that’s basically the effect of this ruling: a big grant of power to Bud Selig to exceed the penalties set forth in the JDA in cases that don’t involve a positive test. A power that, for whatever reason, he decided not to use for Nelson Cruz, Jhonny Peralta and all of the other Biogenesis players, but I suppose that’s convenient too. And, perversely, a power he would not have if the drug testing system he has put in place would have caught these players before we heard about it in the Miami New-Times. Indeed, the failure of the drug testing system worked to Selig’s benefit, which is kind of crazy itself if you think about.

But that’s neither here nor there. The real takeaway here is that Selig now has power in the drug enforcement world he didn’t have before and which he did not obtain via negotiation with the union. He obtained it by simply asserting it and seeing if he could make it stick.  He made it stick.

It’l be interesting to see if the union, under new leader Tony Clark, is going to make this an issue when the new CBA is negotiated or if they’re going to let Selig’s grab for power– his quite successful grab — stand.

Nationals acquire Adam Eaton from White Sox for three top prospects

MINNEAPOLIS, MN - SEPTEMBER 02: Adam Eaton #1 of the Chicago White Sox hits an RBI double against the Minnesota Twins during the ninth inning of the game on September 2, 2016 at Target Field in Minneapolis, Minnesota. The White Sox defeated the Twins 11-4. (Photo by Hannah Foslien/Getty Images)
Hannah Foslien/Getty Images
1 Comment

Update (5:04 PM EST): The White Sox will receive pitchers Lucas Giolito, Reynaldo Lopez, and Dane Dunning from the Nationals, per Dan Hayes of CSN Chicago. MLB Pipeline rated them No. 1, 3, and 6 in the Nationals’ minor league system.

*

Ken Rosenthal of FOX Sports reports that the Nationals are close to acquiring outfielder Adam Eaton from the White Sox. He notes that outfielder Victor Robles, the Nationals’ No. 2 prospect according to MLB Pipeline, is not included in the deal.

Eaton, 28, is signed to a very team-friendly contract. He’ll earn $4 million in 2017, $6 million in ’18, and $8.4 million in ’19. His controlling team then has a club option worth $9.5 million in 2020 with a $1.5 million buyout and a $10.5 million club option in ’21 with a $1.5 million buyout.

This past season, Eaton was worth 3.9 Wins Above Replacement according to Baseball Reference after playing significantly above-average defense while batting .284/.362/.428 with 14 home runs, 59 RBI, 91 runs scored, and 14 stolen bases in 706 plate appearances.

If the deal goes through, the Nationals would move Trea Turner from center field to shortstop. Meanwhile, the White Sox continue their teardown after trading Chris Sale to the Red Sox on Tuesday.

Marlins sign A.J. Ellis to a one-year, $2.5 million deal

NEW YORK, NY - AUGUST 28:  A.J. Ellis #34 of the Philadelphia Phillies reacts after the final out of a game against the New York Mets at Citi Field on August 28, 2016 in the Flushing neighborhood of the Queens borough of New York City.  (Photo by Jim McIsaac/Getty Images)
Jim McIsaac/Getty Images
4 Comments

ESPN’s Buster Olney reports that the Marlins have signed veteran catcher A.J. Ellis to a one-year, $2.5 million deal.

Ellis, 35, began the 2016 season with the Dodgers but went to the Phillies in the Carlos Ruiz trade near the end of August. Overall, he hit .216/.301/.298 in 196 plate appearances.

Ellis will back up J.T. Realmuto behind the dish.